Clinical Trials Sponsored by CR-CSSS Champlain-Charles-Le Moyne

Total 6 results

CR-CSSS Champlain-Charles-Le Moyne

Suspended

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer (BRP30)

Prostate Cancer

Canada
CR-CSSS Champlain-Charles-Le Moyne

Completed

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer (BRP2)

Prostate Cancer

Canada
CR-CSSS Champlain-Charles-Le Moyne

Completed

Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population (VancoDATABayes)

Adult | Vancomycin | Area Under Curve

Canada
CR-CSSS Champlain-Charles-Le Moyne

Completed

Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy (FORESIGHT)

Chemotherapy-induced Nausea and Vomiting

Canada
CR-CSSS Champlain-Charles-Le Moyne

Withdrawn

Audit and Feedback Interventions With Primary Care Nursing Teams

Nurse's Role
CR-CSSS Champlain-Charles-Le Moyne
Sanofi; Regeneron Pharmaceuticals; Quebec Clinical Research Organization in Cancer

Terminated

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Canada

3

Subscribe